FENBEN: 🐶 From Dog Dewormer to Cancer Game-Changer? 💊
Why the “Experts” Hope You Never Read About Fenbendazole (“Fenben”)
Imagine telling your oncologist you’re thinking about taking fenbendazole (yes, the humble dog dewormer) as part of your cancer protocol. You’d probably get a look somewhere between horror and disbelief… maybe even a scolding about “pseudoscience.”
But what if this “horse paste for dogs” actually does have real, research-backed anti-cancer properties? So real, in fact, that the medical establishment would rather you never hear about them?
It turns out that’s precisely what recent studies and independent researchers are finding, and the evidence is piling up faster than the mainstream media and medical mafia can bury it.
📚 The Science Big Pharma Hopes You Ignore
Natural News recently detailed 12 anti-cancer mechanisms of fenbendazole, showing how it:
- Disrupts microtubule formation in cancer cells (kind of like chemo, but without annihilating your immune system)
- Inhibits cancer cell glucose uptake
- Stimulates p53 tumor suppressor genes (often called the “guardian of the genome”)
- Induces apoptosis (programmed cancer cell death)
- Reduces angiogenesis, cutting off blood supply to tumors
But it doesn’t stop there. A 2024 study found that fenbendazole showed effectiveness against KRAS-driven pancreatic cancer, notoriously one of the hardest cancers to treat.
Another fascinating paper in Anticancer Research tested fenbendazole, which showed significant cytotoxic effects against lung, breast, and colon cancer cell lines. And let’s not forget the recent combination studies: when paired with agents like ivermectin and mebendazole, fenbendazole’s anticancer properties appear to be enhanced.
🧬 What Makes Fenbendazole Special?
It comes down to its ability to:
- Disrupt microtubules — the skeleton inside cancer cells
- Reduce cancer cell glucose metabolism (essentially starving the cells)
- Increase oxidative stress within tumors (Read detailed breakdown in Molecules journal here)
Remarkably, all while showing low toxicity in normal cells — unlike many FDA-approved chemo drugs. And yes, mainstream sites are starting to notice too, though predictably, the narrative is “more research needed” and “don’t try this at home.”
🤐 Why You Probably Haven’t Heard About It
If fenbendazole were an expensive, patentable drug, you’d see Big Pharma commercials for it on TV. But since it costs pennies per dose and can’t be patented, it threatens billions in cancer drug profits. So instead, stories of people who tried it — like the famous case of Joe Tippens — spread quietly online, while major journals publish cautious language and mainstream media pretends it’s a “dangerous internet rumor.” And yet, the science (like this study in Journal of Gynecologic Oncology) keeps growing.
Look, we’re not saying fenbendazole is a silver bullet. Cancer is complex, and there’s no one-size-fits-all cure. But dismissing an affordable, low-toxicity compound with multiple proven anti-cancer pathways… just because it’s a dog dewormer? That sounds less like science — and more like industry-driven censorship.
Want to dive deeper?
Check out these studies yourself:
- Anticancer Research study
- BMC Cancer study on KRAS-driven pancreatic cancer
- Molecules study
- Journal of Gynecologic Oncology
- Healthline overview
- Internal Healing & Wellness MD article
Don’t just take their word for it. Read. Think. Question.
Because sometimes, the cure Big Pharma doesn’t want… might already exist …right on the vet’s shelf.
No comments:
Post a Comment